ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Dentifrices

Also written as “Reference Dentifrice” and “Marketed Dentifrice”.

Its studies are mostly in Dental Caries · Gingivitis · Dental Plaque, led by 3 companies.

Drug pageDentifrices: every studyAll 3 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 2, since Apr 4, 20194 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Church & Dwightits history only20 open or runningphase 2since Apr 4, 2019Apr 4, 2019none ahead
HALEON10 open or runningno phasesince Apr 22, 2025Apr 22, 2025none ahead
Procter and Gambleits history only10 open or runningno phasesince Mar 24, 2015Mar 24, 2015none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of HALEON only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Apr 22, 2025First study: no phase study in Dental CariesFirst studyNCT06949072 · 47 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study HALEON leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06949072Dental Caries · United States–CompletedSep 11, 202547

How it is read

Names in the registry

  • “Dentifrices”, 2 entries
  • “Reference Dentifrice”, 1 entry
  • “Marketed Dentifrice”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.